Uniqure Nv Stock Today

QURE Stock  USD 4.71  0.04  0.86%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 59

 
High
 
Low
Above Average
Uniqure NV is trading at 4.71 as of the 19th of April 2024, a 0.86 percent increase since the beginning of the trading day. The stock's lowest day price was 4.66. Uniqure NV has over 59 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for Uniqure NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of February 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
20th of June 2007
Category
Healthcare
Classification
Health Care
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. The company also engages in developing AMT-130, a gene therapy that is in Phase III clinical study for the treatment of Huntingtons disease AMT-060, which is in Phase III clinical trial for the treatment of hemophilia B AMT-210, a product candidate for the treatment of Parkinsons disease AMT-260 for temporal lobe epilepsy AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimers disease and AMT-161 for the treatment of amyotrophic lateral sclerosis. The company has 47.84 M outstanding shares of which 2.48 M shares are at this time shorted by private and institutional investors with about 1.89 trading days to cover. More on Uniqure NV

Moving against Uniqure Stock

  0.54NUVB Nuvation Bio Financial Report 2nd of May 2024 PairCorr
  0.43IMMP Immutep Ltd ADRPairCorr
  0.42MRKR Marker TherapeuticsPairCorr

Uniqure Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Uniqure NV's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Uniqure NV or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEODaniel Soland
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Uniqure NV report their recommendations after researching Uniqure NV's financial statements, talking to executives and customers, or listening in on Uniqure NV's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Uniqure NV. The Uniqure consensus assessment is calculated by taking the average forecast from all of the analysts covering Uniqure NV.
Financial Strength
Based on the key indicators related to Uniqure NV's liquidity, profitability, solvency, and operating efficiency, Uniqure NV is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Uniqure NV is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.01810.019
Notably Down
Pretty Stable
Total Current Liabilities77.4 M73.7 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total577.9 M550.3 M
Sufficiently Up
Slightly volatile
Total Assets873.3 M831.7 M
Sufficiently Up
Slightly volatile
Total Current Assets684.4 M651.9 M
Sufficiently Up
Slightly volatile
Uniqure NV's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Uniqure NV's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Uniqure NV's financial leverage. It provides some insight into what part of Uniqure NV's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Uniqure NV's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Uniqure NV deploys its capital and how much of that capital is borrowed.
Liquidity
Uniqure NV cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 138.41 M in liabilities with Debt to Equity (D/E) ratio of 0.29, which may suggest the company is not taking enough advantage from borrowing. Uniqure NV has a current ratio of 10.62, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Uniqure NV until it has trouble settling it off, either with new capital or with free cash flow. So, Uniqure NV's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Uniqure NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Uniqure to invest in growth at high rates of return. When we think about Uniqure NV's use of debt, we should always consider it together with cash and equity.

Stock Based Compensation

36.85 Million
Uniqure NV (QURE) is traded on NASDAQ Exchange in USA. It is located in Paasheuvelweg 25, Amsterdam, Netherlands, 1105 BP and employs 480 people. Uniqure NV is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 225.32 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Uniqure NV's market, we take the total number of its shares issued and multiply it by Uniqure NV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Uniqure NV conducts business under Biotechnology sector and is part of Health Care industry. The entity has 47.84 M outstanding shares of which 2.48 M shares are at this time shorted by private and institutional investors with about 1.89 trading days to cover. Uniqure NV currently holds about 500.52 M in cash with (145.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Uniqure NV Probability Of Bankruptcy
Ownership Allocation
Uniqure NV shows a total of 47.84 Million outstanding shares. The majority of Uniqure NV outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Uniqure NV to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Uniqure NV. Please pay attention to any change in the institutional holdings of Uniqure NV as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Uniqure Ownership Details

Uniqure Stock Price Odds Analysis

What are Uniqure NV's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Uniqure NV jumping above the current price in 90 days from now is under 95%. The Uniqure NV probability density function shows the probability of Uniqure NV stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.209 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Uniqure NV will likely underperform. Additionally, uniqure NV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 4.71HorizonTargetOdds Above 4.71
5.48%90 days
 4.71 
94.47%
Based on a normal probability distribution, the odds of Uniqure NV to move above the current price in 90 days from now is under 95 (This Uniqure NV probability density function shows the probability of Uniqure Stock to fall within a particular range of prices over 90 days) .

Uniqure Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Uniqure NV that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Uniqure NV's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Uniqure NV's value.
InstituionRecorded OnShares
Vanguard Group Inc2023-12-31
962.8 K
Tang Capital Management Llc2023-09-30
935.8 K
Ameriprise Financial Inc2023-12-31
820.3 K
Jpmorgan Chase & Co2023-12-31
749.4 K
Citigroup Inc2023-12-31
743.9 K
Bnp Paribas Arbitrage, Sa2023-12-31
706.7 K
Macquarie Group Ltd2023-12-31
706.2 K
Citadel Advisors Llc2023-09-30
541.9 K
Geode Capital Management, Llc2023-12-31
479.7 K
Nantahala Capital Management, Llc2023-12-31
5.9 M
Vestal Point Capital Lp2023-12-31
3.9 M
View Uniqure NV Diagnostics

Uniqure NV Historical Income Statement

Uniqure NV Income Statement is one of the three primary financial statements used for reporting Uniqure's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Uniqure NV revenue and expense. Uniqure NV Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Uniqure NV's Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 225.6 M, whereas Operating Income is projected to grow to (268.7 M). View More Fundamentals

Uniqure Stock Against Markets

Picking the right benchmark for Uniqure NV stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Uniqure NV stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Uniqure NV is critical whether you are bullish or bearish towards Uniqure NV at a given time. Please also check how Uniqure NV's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Uniqure NV without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Uniqure NV Corporate Management

Elected by the shareholders, the Uniqure NV's board of directors comprises two types of representatives: Uniqure NV inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Uniqure. The board's role is to monitor Uniqure NV's management team and ensure that shareholders' interests are well served. Uniqure NV's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Uniqure NV's outside directors are responsible for providing unbiased perspectives on the board's policies.

How to buy Uniqure Stock?

Before investing in Uniqure NV, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Uniqure NV. To buy Uniqure NV stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Uniqure NV. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Uniqure NV stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Uniqure NV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Uniqure NV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Uniqure NV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Uniqure Stock please use our How to Invest in Uniqure NV guide.

Already Invested in Uniqure NV?

The danger of trading Uniqure NV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Uniqure NV is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Uniqure NV. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Uniqure NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Uniqure NV is a strong investment it is important to analyze Uniqure NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Uniqure NV's future performance. For an informed investment choice regarding Uniqure Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Uniqure NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Uniqure Stock refer to our How to Trade Uniqure Stock guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Uniqure Stock analysis

When running Uniqure NV's price analysis, check to measure Uniqure NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Uniqure NV is operating at the current time. Most of Uniqure NV's value examination focuses on studying past and present price action to predict the probability of Uniqure NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Uniqure NV's price. Additionally, you may evaluate how the addition of Uniqure NV to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
CEOs Directory
Screen CEOs from public companies around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Uniqure NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Uniqure NV. If investors know Uniqure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Uniqure NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.18)
Earnings Share
(6.47)
Revenue Per Share
0.332
Quarterly Revenue Growth
(0.94)
Return On Assets
(0.22)
The market value of Uniqure NV is measured differently than its book value, which is the value of Uniqure that is recorded on the company's balance sheet. Investors also form their own opinion of Uniqure NV's value that differs from its market value or its book value, called intrinsic value, which is Uniqure NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Uniqure NV's market value can be influenced by many factors that don't directly affect Uniqure NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Uniqure NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Uniqure NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Uniqure NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.